Disrupted-In-Schizophrenia 1 (DISC1) is a promising candidate gene for susceptibility to psychiatric disorders, including schizophrenia. DISC1 appears to be involved in neurogenesis, neuronal migration, axon/dendrite formation and synapse formation; during these processes, DISC1 acts as a scaffold protein by interacting with various partners. However, the lack of Disc1 knockout mice and a well-characterized antibody to DISC1 has made it difficult to determine the exact role of DISC1 in vivo. In this study, we generated mice lacking exons 2 and 3 of the Disc1 gene and prepared specific antibodies to the N-and C-termini of DISC1. The Disc1 mutant mice are viable and fertile, and no gross phenotypes, such as disorganization of the brain's cytoarchitecture, were observed. Western blot analysis revealed that the DISC1-specific antibodies recognize a protein with an apparent molecular mass of ∼100 kDa in brain extracts from wild-type mice but not in brain extracts from DISC1 mutant mice. Immunochemical studies demonstrated that DISC1 is mainly localized to the vicinity of the Golgi apparatus in hippocampal neurons and astrocytes. A deficiency of full-length Disc1 induced a threshold shift in the induction of long-term potentiation in the dentate gyrus. The Disc1 mutant mice displayed abnormal emotional behavior as assessed by the elevated plus-maze and cliff-avoidance tests, thereby suggesting that a deficiency of full-length DISC1 may result in lower anxiety and/or higher impulsivity. Based on these results, we suggest that full-length Disc1-deficient mice and DISC1-specific antibodies are powerful tools for dissecting the pathophysiological functions of DISC1. † These three authors contributed equally to this work.
INTRODUCTION
Although the etiological mechanisms of psychiatric disorders, such as schizophrenia, remain largely esoteric, multiple hypotheses (e.g. dysfunction of dopamine, glutamate or serotonin, neurodevelopmental disorders, stress during pregnancy and viral infection) have been proposed (1, 2) . The dissection of molecular pathways centered on promising risk factors, such as Disrupted-In-Schizophrenia 1 (DISC1), may help us achieve a better understanding of the pathogenesis of these disorders. The DISC1 gene locus was originally identified at the breakpoint of a balanced chromosomal translocation t(1;11)(q42.1;q14.3) that co-segregated with schizophrenia, bipolar disorder and recurrent major depression in a large Scottish family (3, 4) . Further analysis has revealed that the inheritance of the translocation is causal and increases the risk of these psychiatric disorders 50-fold (5) . Genetic association studies of several ethnic groups indicate that DISC1 is a major risk factor for psychiatric disorders, including schizophrenia and mood disorders (6) . In addition, clinical studies have shown that genetic variations in DISC1 influence brain function and anatomy (7) .
Several groups have isolated DISC1-interacting proteins. These proteins include nuclear distribution gene E homolog-like 1 (NDEL1), lissencephaly-1 (LIS1), fasciculation and elongation protein zeta 1 (FEZ1), phosphodiesterase 4B (PDE4B), kinesin family member 5B (KIF5B), growth factor receptorbound protein 2 (GRB2), glycogen synthase kinase 3b (GSK3b), girdin, kalirin, TRAF2 and NCK-interacting kinase (TNIK) and DIX domain-containing 1 (DIXDC1) (8 -19) . These studies suggest that DISC1 is involved in neurogenesis, neuronal migration, axon/dendrite formation and synapse formation through interactions with the abovementioned proteins (20) . DISC1 is thus considered to be a scaffold protein that regulates specific molecular pathways (21) .
To aid our understanding of the physiological function of DISC1, mouse models with various alterations in DISC1 have been developed. These models include mice with missense mutations (22) , overexpression of truncated forms of DISC1 (23 -26) and mice that have a 25 bp deletion in exon 6 of the Disc1 gene [hereafter termed Disc1 (D6) mice] (27, 28) . Anatomical and behavioral analyses of these mice have revealed abnormal phenotypes, such as schizophrenia and/or depression-related phenotypes (21) . However, the pathophysiological and behavioral functions of DISC1 are controversial, and possible unknown splice variants of Disc1 hinder efforts to resolve this problem (29) . To further understand the physiological role of DISC1 and its relationship to psychiatric disorders, Disc1 knockout mice and a wellcharacterized antibody to DISC1 are required.
In this study, we generated mice lacking exons 2 and 3 of the Disc1 gene by homologous recombination in embryonic stem (ES) cells. These mice are hereafter to be termed Disc1 (D2-3) mice. We also made new antibodies against DISC1 for use in evaluating the Disc1 (D2-3) mice and analyzing DISC1 function. Western blot analysis revealed that the DISC1 antibodies recognize a polypeptide with a molecular mass of 100 kDa in wild-type mice but not in the Disc1 (D2-3) mice. Immunochemical analysis revealed that these DISC1 antibodies recognized endogenous DISC1 that was mainly localized to the vicinity of the Golgi apparatus in hippocampal neurons and astrocytes. Gross anatomical abnormalities were not evident in the Disc1 (D2-3) mice, but electrophysiological analyses revealed that the threshold for the induction of long-term potentiation (LTP) was significantly higher than in normal mice. Additionally, behavioral tests revealed a phenotype characterized by gender-independent higher impulsivity as well as gender-dependent deficits of prepulse inhibition (PPI) and increased responsiveness to methamphetamine (METH).
RESULTS

Generation of mice lacking exons 2 and 3 of Disc1
Although many splice variants of Disc1 at the protein and mRNA levels have been reported (3, 15, (30) (31) (32) , the major form of DISC1 appears to have a molecular mass of 100 kDa, which corresponds to the size of the mouse full-length Disc1 mRNA. Because each of the putative isoforms contain exons 2 and 3 (30) , exons 2 and 3 of Disc1 were replaced with a loxP/ PGK-Neo-pA/loxP cassette, and an in-frame stop codon was inserted between the remaining exon 2 and the loxP site in mouse TT2 ES cells from an F1 embryo between a C57BL/6 and CBA cross and HK3i ES cells from a C57BL/6N embryo ( Fig. 1A and B; http://www.cdb.riken.jp/arg/ES_cells.html). Many proteins, including PDE4B, KIF5B, GSK3b, girdin and TNIK, associate with DISC1 through the region encoded by exons 2 and 3 (8, 10, 12, 13, 17) . Thus, the function of DISC1 as a scaffold protein that interacts with these proteins is lost in mice lacking exons 2 and 3 of Disc1. Homologous recombination was confirmed by southern blot analysis (Fig. 1C ) and genomic polymerase chain reaction (PCR) (Fig. 1D ). Mice heterozygous for the Disc1 mutation (hereafter termed Disc1 +/D2-3 mice) were backcrossed onto the C57BL/6JJmsSlc background for at least five generations to generate Disc1 +/D2-3 mice with a predominantly C57BL/6J genetic background (100/100 marker at N5). The Disc1 +/D2-3 mice appeared normal and were healthy and fertile. Mice homozygous for the Disc1 mutation (hereafter termed Disc1 D2-3/D2-3 mice) were produced at the expected Mendelian ratio by intercrossing Disc1 +/D2-3 mice. The Disc1 D2-3/D2-3 mice were also viable and fertile and showed no obvious differences in physical characteristics from the Disc1 +/D2-3 mice. Reverse transcription (RT)-PCR analysis revealed that the mRNA derived from exons 2 and 3 of Disc1 were absent in the Disc1 D2-3/D2-3 mice, whereas exons 7-10 of Disc1 were detected in both wild-type (hereafter termed Disc1 +/+ ) and Disc1 D2-3/D2-3 mice ( Fig. 1B and E) . Because both commercial and previously generated antibodies to DISC1 showed high background levels when used for western blot analysis, two different polyclonal antibodies were developed (Fig. 1B) . The N-terminal antibody detected two major protein bands with molecular masses of 100 and 45 kDa as assessed by western blot analysis ( Fig. 1F  and Supplementary Material, Fig. S1A ). The 100 kDa band was absent in the Disc1 D2-3/D2-3 mouse brain lysate but not in the Disc1 +/+ mouse brain lysate. In contrast, the 45 kDa band was present in lysates from both Disc1 +/+ and Disc1 D2-3/D2-3 mice. This result indicated that the 45 kDa band may represent a nonspecific signal. The C-terminal antibody detected a protein band with a molecular mass of 100 kDa. Similarly, the 100 kDa band was absent in the Disc1 D2-3/D2-3 mouse brain lysate but present in the Disc1 +/+ mouse brain lysate ( Fig. 1G and Supplementary Material, Fig. S1B ). To further examine whether the antibody recognized DISC1, DISC1 was immunoprecipitated from mouse brain extracts using both the N-terminal and Cterminal antibodies and the peptides derived from exons 5 and 6 of Disc1 were detected in the immunoprecipitate by the liquid chromatography tandem mass spectrometry analysis. Taken together, these results indicate that the Disc1 D2-3/D2-3 mice do not express DISC1 isoforms containing exons 2 and 3. However, we cannot dismiss the possibility that truncated forms of DISC1 lacking exons 2 and 3 were produced from unidentified start sites in Disc1 mRNA. ; D/D) mice. Genomic DNA was digested with ApaI and subjected to hybridization with the probe. DNA fragments of 14.5 and 24 kbp correspond to the wild-type and the Disc1 (D2-3) mutant alleles, respectively. (D) PCR genotyping of the Disc1 (D2-3) mice. PCR products of 547 and 619 bp correspond to the wild-type and the Disc1 (D2-3) mutant alleles, respectively. (E) RT-PCR analysis of the Disc1 (D2-3) mice. Total RNA prepared from P7 brain tissue was reverse transcribed and used for PCR amplification with primers specific for exons 2-3 and exons 7 -10 of Disc1 and a housekeeping gene (Hprt). An amplification product for exons 2-3 was not observed in the Disc1 D2-3/D2-3 mice. However, exons 7-10 were detected in both Disc1 +/+ and Disc1 D2-3/D2-3 mice. (F and G) Western blot analysis of the Disc1 (D2-3) mice. P7 brain lysates were blotted with antibodies specific for the DISC1 N-terminal (F) and C-terminal (G) regions. The arrowhead indicates the position of full-length DISC1. A 45 kDa protein band observed with the N-terminal antibody may be a nonspecific signal.
Morphological defects in brain development were not observed in the Disc1 D2-3/D2-3 mice
Despite the results of the western blot analysis, which showed abundant expression of DISC1 in the brain during early development (Supplementary Material, Fig. S3B and C), Disc1 D2-3/D2-3 embryos appeared normal upon examination (data not shown), indicating that DISC1 is probably dispensable for embryogenesis. The Disc1 D2-3/D2-3 mice develop and reproduce normally with no apparent morphological effects in the examined organs, including the brain, through postnatal (P) day 56, which may reflect the ability of other proteins to compensate for the absence of DISC1. No appreciable abnormalities in the volume of the cerebrum, the cerebellum or the olfactory bulb were observed in the brains of the Disc1 D2-3/D2-3 mice in comparison to their Disc1 +/+ littermates during the postnatal period or in adulthood ( Fig. 2A ). An examination of brain structure using Nissl staining revealed a nearly normal cytoarchitecture of the neocortex, the basal ganglia and the hippocampus in the Disc1 D2-3/D2-3 mice at P56 (Fig. 2B and C) . Interestingly, the Disc1 D2-3/D2-3 mice exhibited no reduction in the size of the white matter tracts, such as the corpus callosum and anterior and posterior commissures (Fig. 2C ). In addition, the volume of the prefrontal cortex (Fig. 2C) , which is a structure that has been implicated as a locus of dysfunction in schizophrenia (33, 34) , did not appear to be reduced.
Evaluation of commercially available anti-DISC1 antibodies
Several DISC1 antibodies are commercially available. During the course of generating Disc1 (D2-3) mice, we noticed that none of the commercial antibodies recognized the 100 kDa protein band that was absent in the Disc1 D2-3/D2-3 mice (Supplementary Material, Fig. S1C ). Of note, one antibody strongly reacted with a protein band with a molecular mass of 100 kDa. However, this immunoreactivity was not lost in brain extracts from the Disc1 D2-3/D2-3 mice, although the antigen recognized by this antibody was included in exon 2. Because the expression level of endogenous DISC1 is low, even in the brain (Supplementary Material, Fig. S3B and C), it was difficult to detect endogenous DISC1 using the commercially available antibodies under our conditions.
Mouse strains defective in DISC1 expression
Gogos and associates identified a 25 bp deletion in exon 6 of Disc1 in the 129 strains of mice [Disc1 (D6) mice] (27, 35) . These researchers claimed that this mutation interfered with the production of full-length DISC1 (27, 28) . We determined whether full-length DISC1 was expressed in brain extracts from 129X1/SvJJmsSlc mice using our C-terminal antibodies (these mice, which are homozygous for the deletion of the allele, are hereafter termed Disc1 D6/D6 mice). The 100 kDa ) and none of the ICR mice had homozygous wild-type alleles (Disc1 +/+ ). The C-terminal antibody recognized the 100 kDa band in the Disc1 +/+ mice but not in the Disc1 D6/D6 mice of the ddY and ICR strains (Supplementary Material, Fig. S2 ).
Spatiotemporal expression pattern of DISC1 in mice
In situ hybridization and northern blot analysis have shown that Disc1 mRNA is chiefly expressed in the mouse cerebrum, cerebellum and heart during development (3, 14, (36) (37) (38) (39) . To obtain an overview of the spatiotemporal expression pattern of the DISC1 protein in mice, a western blot analysis was performed using the C-terminal antibody. Expression of DISC1 was detected in various tissues of prenatal mice (Supplementary Material, Fig. S3A ). DISC1 was highly expressed in the cerebellum and the lung and was moderately expressed in the cerebrum, the brainstem, the heart and the kidney. The developmental profile of DISC1 expression in the cerebrum and the cerebellum was further analyzed (Supplementary Material, Fig. S3B and C). The expression of DISC1 peaked during the postnatal period and gradually declined thereafter. The amount of DISC1 protein in the cerebrum and the cerebellum was roughly calculated by quantitative western blot analysis using the recombinant DISC1 protein as a standard. The amount of DISC1 in the whole cerebrum and the whole cerebellum was estimated as 0.0002% and 0.0003% of the total protein, respectively, suggesting that DISC1 is a low-abundance protein.
Immunochemical analysis of DISC1 in hippocampal neurons and astrocytes
To further examine whether our antibodies recognized endogenous DISC1 in vivo and in vitro, immunofluorescent staining was performed with the C-terminal antibody in brain sections from P2 mice and in cultured hippocampal neurons. In brain sections, DISC1 immunoreactivity was localized in the pyramidal cell layer of the hippocampal CA1 and CA3 regions (Fig. 3A and B) , which was consistent with the results of previous studies using in situ hybridization (14,36 -39) . Immunostaining with the DISC1 antibody and organelle-specific antibodies revealed that DISC1 immunoreactivity was mainly localized to the vicinity of the Golgi apparatus ( Fig. 3C and D) . The immunoreactivity of DISC1 was diminished in the Disc1 D2-3/D2-3 mice ( Fig. 3B and D) . To analyze the subcellular distribution of DISC1 further, immunoelectron microscopic analysis was performed in hippocampal CA1 pyramidal cells stained with the C-terminal antibody. DISC1 immunoreactivity was detected in the vicinity of the Golgi apparatus at the base of the apical dendrites ( Fig. 3E -G) .
In cultured hippocampal neurons and astrocytes, DISC1 was mainly localized to the vicinity of the Golgi apparatus ( Fig. 4A -D) . In the immunoelectron microscopic analysis of hippocampal neurons labeled with the C-terminal antibody, the DISC1 immunoreactivity was associated with the membrane structures of the Golgi apparatus (Fig. 4E ).
Electrophysiological analyses in the Disc1
D2-3/D2-3 mice
Because Disc1 mRNA is highly expressed in the dentate gyrus of the hippocampus (14, (36) (37) (38) (39) , the effects of the disruption of exons 2 and 3 of the Disc1 gene were investigated on the synaptic properties of neurons in the dentate gyrus in mouse hippocampal slices using an extracellular recording technique. First, the strength of basal synaptic transmission was compared at medial perforant path-dentate granule cell synapses between Disc1 +/+ and Disc1 D2-3/D2-3 mice. Basal synaptic transmission was estimated by measuring the amplitude of a presynaptic fiber volley (PSFV) and the initial slope of the field excitatory postsynaptic potentials (fEPSPs) over a range of stimulus intensities. As seen in Supplementary Material, Figure S4A , the stimulus -PSFV relationships in both Disc1 +/+ and Disc1 D2-3/D2-3 mice were almost linear, and the PSFV amplitude in both groups was nearly identical at every stimulus intensity that was tested [two-way analysis of variance (ANOVA), F(1,126) ¼ 0.59, P . 0.1, n ¼ 10). In the stimulus-fEPSP relationships, the mean value of the fEPSP slope in the Disc1 D2-3/D2-3 mice was smaller than in the Disc1 +/+ mice over the stimulus range, but the difference was not significant [two-way ANOVA, F(1,126) ¼ 1.46, P . 0.1, n ¼ 10, Supplementary Material, Fig. S4B ]. The mean value of the fEPSP slope evoked by test stimuli ( 50% of the maximum response) was 20.51 + 0.14 mV/ms in the Disc1 +/+ mice (n ¼ 10) and 20.48 + 0.12 mV/ms in the Disc1 D2-3/D2-3 mice (n ¼ 10). The synaptic responses to weaker high-frequency stimulation (HFS, 50 Hz/100 pulses), standard HFS (100 Hz/100 pulses) and stronger HFS (200 Hz/100 pulses) were subsequently examined in the Disc1 +/+ and Disc1 D2-3/D2-3 mice. In hippocampal slices from the Disc1 +/+ mice, weaker HFS resulted in an enhancement of the fEPSP slope that persisted for over 60 min, which was indicative of LTP (123.3 + 2.0% of baseline 60 min after weaker HFS, n ¼ 4, P , 0.001, paired t-test, Fig. 5A and D). However, in hippocampal slices from the Disc1 D2-3/D2-3 mice, the same protocol did not induce LTP but instead produced a phenomenon similar to short-term depression (109.7 + 8.1% of baseline after weaker HFS, n ¼ 5, P ¼ 0.056, paired t-test, Fig. 5A and D). In contrast, standard HFS-induced LTP in slices from the Disc1 +/+ and Disc1 D2-3/D2-3 mice with a significantly smaller magnitude of LTP in the Disc1 D2-3/D2-3 mice at 60 min after standard HFS (Disc1 +/+ , 130.8 + 6.1% of baseline 60 min after standard HFS, n ¼ 4, P ¼ 0.002, paired t-test; Disc1 D2-3/D2-3 , 117.7 + 7.0% of baseline 60 min after standard HFS, n ¼ 5, P ¼ 0.005, paired t-test, Fig. 5B and D) . Notably, the form and magnitude of the standard HFS-induced LTP in the Disc1 D2-3/D2-3 mice were similar to those of the weaker HFS-induced LTP in the
Disc1
+/+ mice. When a stronger HFS was used to induce LTP, the magnitude of the LTP was significantly larger in the Disc1 D2-3/D2-3 mice than in the Disc1 , 134.9 + 4.0% of baseline 60 min after a stronger HFS, n ¼ 4, P , 0.001, paired t-test, Fig. 5C and D). However, the magnitude of the stronger HFS-induced LTP in the Disc1 D2-3/D2-3 mice +/+ mice. Golgi apparatus (arrow) was composed of stacks of membranebound structures known as cisterna and localized at the base of apical dendrites (AD). DISC1 immunoreactivity (arrowhead) was detected in the vicinity of the Golgi apparatus near the nucleus (N). The scale bar represents 100 mm (A and B), 10 mm (C and D), 3 mm (E), 500 nm (F) and 100 nm (G).
was similar to that of the standard HFS-induced LTP in the Disc1 +/+ mice. The frequency dependencies of LTP magnitude in the Disc1 +/+ and Disc1 D2-3/D2-3 mice were summarized by plotting the normalized fEPSP slope at 55-60 min after HFS delivery against HFS frequency as shown in Figure 5D . In the Disc1 D2-3/D2-3 mice, a higher frequency of HFS was needed to produce an equivalent LTP magnitude to that induced in the Disc1 +/+ mice. These results suggest that LTP can be induced in the synapses of Disc1 D2-3/D2-3 mice but that the threshold for LTP induction is increased by the disruption of exons 2 and 3 of the Disc1 gene. D2-3/D2-3 mice compared with the activity of the Disc1 +/+ mice (Table 1) . Abnormalities in emotional and social behavior were observed in adult Disc1 D2-3/D2-3 mice (12 -24 weeks old). These behaviors were assessed using the elevated plus-maze test, the cliff-avoidance test and the social interaction test (Table 2 ). In the elevated plus-maze test, open arm time was significantly increased, whereas closed arm time was significantly decreased in the Disc1 D2-3/D2-3 mice compared with the Disc1 +/+ mice (P , 0.01, Fig. 6A and B) . The Disc1 D2-3/D2-3 mice also exhibited a marked increase in open and closed arm entries compared with the Disc1 +/+ mice (P , 0.05, Supplementary Material, Fig. S5A and B) . In the cliff-avoidance test, the number of jumping events during a 10 min observation period was significantly increased in the Disc1 D2-3/D2-3 mice compared with the Disc1 +/+ mice (P , 0.05, Fig. 6C ). Furthermore, the cumulative frequency of the first jumping off of the platform during a 3 min observation period was significantly increased in the female Disc1 (Table 2) . With respect to cognitive function, adult Disc1 D2-3/D2-3 mice, especially females, exhibited an impairment of sensorimotor gating as indicated by PPI deficits (P , 0.05, Fig. 6E -G) without changes in the acoustic startle amplitude (Supplementary Material, Fig. S6I ). Adult Disc1 D2-3/D2-3 mice were generally normal with respect to various learning and memory tests, including the Y-maze test, the novel object recognition test and the working memory test using the radial arm maze (Table 2 and Supplementary Material, Fig. S5J -L) . Context-dependent conditioned fear freezing was significantly enhanced in the Disc1 D2-3/D2-3 mice compared with the Disc1 +/+ mice (P , 0.05, Fig. 6H ), although no significant difference in tone-dependent freezing time (Fig. 6I ) or sensitivity to an electric footshock was observed between the two groups (0.19 + 0.01 mA in the Disc1 +/+ mice, 0.18 + 0.01 mA in the Disc1 D2-3/D2-3 mice). Latent inhibition of tonedependent freezing was also normal in adult Disc1 D2-3/D2-3 mice (Table 2) .
Finally, sensitivities to METH, which is an indirect dopaminergic agonist, and MK-801, a non-competitive Nmethyl-D-aspartate (NMDA) receptor antagonist, were determined in adult Disc1 D2-3/D2-3 mice. In the Disc1 +/+ and Disc1 D2-3/D2-3 mice. In the Disc1 D2-3/D2-3 mice, the higher frequency of HFS than the Disc1 +/+ mice was needed to produce an equivalent LTP magnitude to that in the Disc1 +/+ mice. Comparisons between Disc1 +/+ and Disc1 D2-3/ D2-3 mice were made using a two-tailed independent t-test.
mice [F(1,18) ¼ 9.83, P , 0.05] (Fig. 6J -L) . There was no difference between the Disc1 D2-3/D2-3 and Disc1 +/+ mice in their sensitivity to MK-801 ( Table 2) .
Effect of clozapine treatment on the Disc1
Because the behavioral analysis of the Disc1 D2-3/D2-3 mice was significantly ameliorated by treatment with clozapine (P , 0.05, Fig. 7A ). Treatment with clozapine also rescued the decrease in the time spent in the closed arms by the Disc1 D2-3/D2-3 mice (P , 0.05, Fig. 7B ). Clozapine treatment had no effect on the performance of Disc1 +/+ mice in the elevated plus-maze test (Fig. 7 and Supplementary Material, S6 ).
Monoamines and their metabolite levels in the brains of adult Disc1
In general, no differences between the Disc1 D2-3/D2-3 mice and the Disc1 +/+ mice regarding monoamine levels or metabolite contents were observed in any of the various brain regions that were examined. In one exception, a slight but significant reduction in serotonin content was observed in the cerebellum of the Disc1 D2-3/D2-3 mice compared with the Disc1 +/+ mice (Table 3) .
DISCUSSION
We generated mice lacking exons 2 and 3 of Disc1 [Disc1 (D2-3) mice] and made specific antibodies to the N-and C-termini of DISC1. Western blot analysis using either antibody detected a protein band with a molecular mass of 100 kDa that was absent in brain lysates from the Disc1 D2-3/D2-3 mice. Mass spectral analysis determined that the N-terminal and C-terminal antibodies recognize the endogenous mouse DISC1. We also confirmed that the fulllength DISC1 was not expressed in brain extracts of mice with a 25 bp deletion in exon 6 of Disc1 [Disc1 (D6) mice]. These results indicate that the 100 kDa protein is the major isoform of DISC1. However, we cannot neglect the possibility of the existence of other isoforms, although the expression levels of other isoforms, if present, are much lower than that of the 100 kDa DISC1.
DISC1 interacts with many proteins, including NDEL1, LIS1, FEZ1, PDE4B, KIF5B, GRB2, GSK3b, girdin, kalirin, TNIK and DIXDC1 (8 -19) . A number of these proteins interact with DISC1 through the region encoded by exons 2 and 3 (21) . Therefore, the function of DISC1 as a scaffold protein, which requires interaction with these proteins, should be lost in Disc1 (D2-3) mice.
To understand the physiological significance of DISC1, many laboratories, including our own, have knocked down the expression of DISC1 using small interfering RNA or short hairpin RNA (8, (10) (11) (12) (16) (17) (18) (19) (40) (41) (42) (43) (44) (45) (46) (47) . Although the acute knockdown of DISC1 impairs neuronal migration, axon elongation, dendritic maturation and neurogenesis, the Disc1 D2-3/D2-3 mice showed nearly normal cytoarchitecture of the neocortex, the basal ganglia and the hippocampus and no reduction in the size of the white matter tracts or the volume of the prefrontal cortex. Thus, a detailed analysis will be required to examine the structural changes that may occur in the Disc1 D2-3/D2-3 mice. Chronic depletion of DISC1 may induce molecular compensation during development. To overcome this complicating factor, the generation of a conditional Disc1 knockout mouse is necessary.
Our immunohistochemical studies revealed that DISC1 is localized to the vicinity of the Golgi apparatus in hippocampal neurons and astrocytes. Previous studies have shown that both NDEL1 and LIS1 are localized in the Golgi apparatus (48, 49) . DISC1 can associate with ARFGEF2, PACS1 and GM130 (17, 50) , all of which are involved in vesicle trafficking from the Golgi apparatus. Thus, it is possible that DISC1 localizes to the peripheral region of the Golgi apparatus by virtue of its association with these proteins. DISC1 may participate in vesicle movement from the Golgi apparatus. DISC1 is also known to interact with KIF5B, NDELl and LIS1 and to act as a cargo adapter linking kinesin and dynein to cargo proteins, such as NDEL1/LIS1 and GRB2 (16, 17) . Although DISC1 has been reported to be localized in the mitochondria (46,51,52), we did not detect immunoreactivity of DISC1 in association with these organelles. This discrepancy may be explained by the fact that the previous studies were performed using a commercial antibody. However, we cannot dismiss the possibility that under the conditions used, our antibody did not detect mitochondriaassociated DISC1. Electrophysiological analyses of the dentate gyrus of mouse hippocampal slices were conducted to examine the effect of the disruption of exons 2 and 3 of the Disc1 gene on synaptic functions. There was no difference in basal synaptic transmission at the medial perforant path-granule cell synapses in the Disc1 +/+ and Disc1 D2-3/D2-3 mice. In contrast, though HFS-induced LTP could be observed at these synapses in the Disc1 D2-3/D2-3 mice, the threshold for LTP induction was significantly higher than in the Disc1 +/+ mice. Such a threshold shift in the LTP induction is observed in metaplasticity, which has been proposed to relate to higher order brain functions (53) . The factors that contribute to the induction of metaplasticity are diverse. For example, glialderived D-serine affects NMDA receptor activity in such a way that it shifts the threshold for LTP in the rat hypothalamic supraoptic nucleus (54) . Studies of the hippocampus have revealed that pregnenolone sulfate, which is one of the most abundant neurosteroids, induces a modulatory metaplasticity in an L-type voltage-gated calcium channeldependent manner (55) and that brain-derived neurotrophic factor (BDNF) is likely to alter the capacity for plastic changes in synaptic efficacy (56) . Interestingly, it has been reported that serum levels of D-serine, neurosteroids and BDNF are altered in schizophrenia (57) (58) (59) (60) (61) (62) . The relationship between these factors and DISC1 function represents an intriguing subject for study that may lead to an understanding of the mechanisms through which DISC1 affects synaptic transmission and higher order brain functions.
Adult, but not juvenile, Disc1 D2-3/D2-3 mice displayed abnormal emotional behavior as assessed by the elevated plus-maze test and the cliff-avoidance test. This observation suggests that disruption of exons 2 and 3 of the Disc1 gene may cause behavioral effects that are dependent upon neurodevelopment and that result in lower anxiety and/or higher impulsivity in adult mice. The Disc1 D2-3/D2-3 mice also exhibited increased social interaction with an unfamiliar intruder mouse during the social interaction test and increased exploration time of novel objects in the novel object recognition test; both of these behaviors may be associated with lower anxiety/ higher impulsivity. The higher impulsivity observed in the Disc1 D2-3/D2-3 mice is consistent with the clinical features of patients with schizophrenia (63,64). Clozapine is an atypical antipsychotic that has been shown to attenuate a broad range of symptoms in subjects with schizophrenia (65) . In our analysis of the effects of acute administration of clozapine to Disc1 D2-3/D2-3 mice on performance in the elevated plus-maze test, clozapine-treated Disc1 D2-3/D2-3 mice no longer exhibited deficits in the time spent in the open arms and closed arms, which indicated that the emotional deficits in these mice, such as lower anxiety and/or higher impulsivity, were attenuated by treatment with clozapine. These results suggest that deficiency of DISC1 function can be rescued by treatment with antipsychotic drugs; this finding may reflect the therapeutic effects of such drugs on psychotic symptoms in patients with schizophrenia.
Interestingly, the Disc1 D2-3/D2-3 female mice exhibited more severe deficits in some behavioral tests, such as the PPI test, the cliff-avoidance test and the METH-induced hyperactivity test than did the male Disc1 D2-3/D2-3 mice. Consistent with the observed gender-dependent changes in behavior, our in vivo dialysis study revealed gender-dependent alterations of METH-induced dopamine release in the nucleus accumbens of the Disc1 D2-3/D2-3 mice (data not shown). Although the reason for this gender difference remains unclear, sex hormones may play a role. For instance, it has been demonstrated that an increase in the plasma level of female hormones (e.g. estrogen and progesterone) impairs sensorimotor gating (66 -68) .
In this study, we demonstrated that the Disc1 D2-3/D2-3 mice showed PPI deficits, which are a well-known phenomenon observed in patients with schizophrenia and other neuropsychiatric disorders (69) . Such deficits have been observed in most genetically engineered mouse models with mutated DISC1 (Table 4 ). In contrast, our newly developed Disc1 D2-3/D2-3 mice displayed the potentiation of contextdependent fear memory, whereas other memory functions, including cue-dependent fear memory and working memory, did not differ from those of wild-type mice. Therefore, it seems unlikely that DISC1 plays an indispensable role in learning and memory in mice.
Previous reports have demonstrated that genetically engineered mouse models with mutated DISC1 show decreased social interaction and memory impairment (22 -25) . The present findings are somewhat inconsistent with these reports; this discrepancy may be due to the presence of different amounts and/or functions of DISC1 in different genetically engineered mice. The present study generated mice with targeted deletions in DISC1; in these mice, intact DISC1 was not expressed in the brain, while other previously reported mouse models express intrinsic and/or extrinsic DISC1 (Table 4) (22) (23) (24) (25) 27, 28, 45, 70, 71) .
Altered monoaminergic neurotransmission has been reported in patients with schizophrenia (72) , and these alterations may be associated with behavioral abnormalities (73) . There were few differences in the tissue content of monoamines and their metabolites in the brain tissue of Disc1 D2-3/D2-3 and wild-type mice. Therefore, it seems reasonable to infer that the development of monoaminergic neurons is largely unaffected by the loss of DISC1 in mice. However, because METH-induced hyperactivity and dopamine release in the nucleus accumbens were potentiated in the Disc1 D2-3/D2-3 mice, further studies that examine potential alterations in dopaminergic neurotransmission in the Disc1 D2-3/D2-3 mice are warranted.
MATERIALS AND METHODS
Generation of Disc1 (D2-3) mice
Disc1 (D2-3) mice (Acc Nos CDB0583K and CDB0678K: http://www.cdb.riken.jp/arg/mutant%20mice%20list.html) were generated by gene targeting in TT2 ES cells (74) and HK3i ES cells (75) as described previously (http://www.cdb. riken.jp/arg/protocol.html). The targeting vector was designed to replace most of exon 2 and all of exon 3 with a loxP/ PGK-Neo-pA/loxP cassette (http://www.cdb.riken.jp/arg/ca ssette.html) and to insert an in-frame stop codon between the remainder of exon 2 and the loxP site. Successful homologous recombination was confirmed in two clones of the TT2 ES cells (#5, #33) and two clones of the HK3i ES cells (#24, #146) by PCR (forward primer, 5
′ -GTA CTC GGA TGG AAG CCG GTC TTG TC-3 ′ ; reverse primer, 5 ′ -GGT TTC AGA GGA TCC TCC GTT CAC C-3 ′ ) and southern blot analysis with a 5 ′ probe and a 3 ′ probe; the clones yielded highly chimeric mice. The heterozygous offspring were intercrossed to obtain homozygous mutants, which were genotyped by southern blot analysis with a 5 ′ probe and PCR using a mixture of three primers (forward primer 'Wt', 5
′ -GGT CAG AGC TCA GAG AAC TCC TTG TGG-3 ′ , forward primer 'Neo', 5 ′ -CAT CGC CTT CTA TCG CCT TCT TGA CG-3 ′ ; reverse primer 'Rev', 5 ′ -GCT TCC TAC AGA GCA GAC TCC ACA CC-3 ′ ). Primers Wt and Rev amplified the wild-type allele (547 bp), and primers Neo and Rev amplified the mutated allele (619 bp). Four strains of Disc1 (D2-3) mice derived from four different clones of ES cells showed identical phenotypes. For the analysis of the mutant mice, a marker-assisted selection congenic strategy was employed. Clone #33-derived mice, which had 75% C57BL/6 and 25% CBA background in the N1 generation, were backcrossed with C57BL/6JJmsSlc more than five times such that all 100 markers corresponded to C57BL/ 6 alleles. Histological and behavioral analyses were performed using littermates (both males and females) generated by crossbreeding of the backcrossed clone #33 mice. C57BL/ 6JJmsSlc, 129X1/SvJJmsSlc, Slc:ddY and Slc:ICR mice were obtained for breeding from SLC (Hamamatsu, Shizuoka, Japan). Mice were genotyped for the 25 bp deletion in Disc1 (D6) using PCR primers (forward primer, 5
′ -GCT GTG ACC TGA TGG CAC T-3 ′ ; reverse primer, 5 ′ -GCA AAG TCA CCT CAA TAA CCA-3 ′ ) as described previously (35) . All of the animal protocols were approved by the Animal Care and Use Committee of the Nagoya University Graduate School of Medicine, and the Principles for the Care and Use of Laboratory Animals, which were approved by the Japanese Pharmacological Society and the National Institutes of Health Guide for the Care and Use of Laboratory Animals, were followed.
RNA extraction and RT -PCR
Total RNA was extracted from P7 mouse brain tissue samples using the RNeasy Lipid Tissue Mini Kit (QIAGEN, Hilden, Germany). Reverse transcription was performed with 1 mg of RNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Science, Mannheim, Germany). PCR amplification was performed using an Ex-Taq system (Takara Bio, Otsu, Shiga, Japan) with 35 cycles for Disc1 exons 2 -3 (forward primer, 5 ′ -GAA TGT GGC ACG GTC TCC TC-3 ′ ; reverse primer, 5 ′ -TAA TCG CCA TCC TCG ACC AC-3 ′ ) and Disc1 exons 7-10 (forward primer, 5
′ -TGG CTG TCA GAG AAC TCA CTG CTC AG-3 ′ ; reverse primer, 5
′ -CCA TGC ACT TCA CAG TGT TTG CCT TCA-3 ′ ). PCR amplification for Hprt was also performed using PCR primers (forward primer, 5
′ -CCT GCT GGA TTA CAT TAA AGC ACT G-3 ′ ; reverse primer, 5 ′ -GTC AAG GGC ATA TCC AAC AAC AAA C-3 ′ ) as described previously (26) .
Plasmid construction and protein purification cDNA encoding murine DISC1 (mDISC1) was generously provided by Dr Akira Sawa (Johns Hopkins University, Baltimore, MD, USA). The mDISC1 cDNA (amino acid residues 1 -852 of mDISC1) was inserted into the pGEX-4T-2 vector (GE Healthcare, Uppsala, Sweden). An mDISC1 C-terminal fragment (amino acid residues 658 -852 of mDISC1) was inserted into the pGEX-4T-2 and pMAL-c2 vectors (New England Biolabs, Ipswich, MA, USA). The cDNA encoding full-length dnaK was cloned from BL21 (DE3) Escherichia coli cells. Next, dnaK was amplified by PCR and subcloned into the pGEX-6P-3 vector (GE Healthcare). The identity of each fragment was confirmed by DNA sequencing. The MBP-mDISC1 C-terminal protein was produced in BL21 (DE3) E. coli cells and was purified on an amylose resin (New England Biolabs). The GST-mDISC1 C-terminal and GST-dnaK proteins were produced in BL21 (DE3) E. coli cells and were purified with glutathione-Sepharose 4B beads (GE Healthcare). The MBP-mDISC1 C-terminal and GST-mDISC1 C-terminal proteins were bound to a Mono Q column (GE Healthcare) and eluted with a linear gradient (0-1000 mM NaCl in 20 column volume). A full-length GST-mDISC1 protein was produced in Rosetta-gami 2 E. coli cells (Merck, Darmstadt, Germany) and purified with glutathione-Sepharose 4B beads.
Antibodies
Four guinea pig anti-DISC1 N-terminal antibodies were prepared by Medical & Biological Laboratories Co., Ltd. (MBL, Nagoya, Aichi, Japan) and purified using specific peptides (amino acid residues 131 -170 of mDISC1) as antigens. Two rabbit and two guinea pig anti-DISC1 C-terminal antibodies were prepared by MBL. To generate rabbit and guinea pig polyclonal antibodies against the C-terminal region of DISC1, the MBP-mDISC1 C-terminal protein was used as the antigen. The antiserum was precleared using GST-dnaK protein immobilized to CNBr-activated Sepharose 4B beads (GE Healthcare). The anti-DISC1 C-terminal antibody was affinity-purified from the precleared antiserum using the GST-mDISC1 C-terminal protein immobilized on CNBr-activated Sepharose 4B beads. Antibodies against DISC1 (Mid and C-ter, rabbit polyclonal, Invitrogen, Carlsbad, CA, USA and N-16, goat polyclonal, Santa Cruz Biotechnology, Santa Cruz, CA. USA), GM130 (mouse monoclonal, BD, Franklin Lakes, NJ, USA) and glyceraldehyde-3-phosphate dehydrogenase (mouse monoclonal, Invitrogen) were purchased.
Tissue lysates
All of tissue lysates were extracted by the addition of RIPA buffer [20 mM Tris -HCl (pH 7.5), 1 mM EDTA, 150 mM NaCl, 1.0% NP-40, 0.1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS) and Complete Protease Inhibitor Cocktail (Roche Applied Science)]. Protein concentrations were determined using the bicinchoninic acid Protein Assay Reagent Kit (Pierce, Rockford, IL, USA). The lysates were boiled with 3× SDS -polyacrylamide gel electrophoresis (PAGE) sample buffer [187.5 mM Tris -HCl (pH 6.8), 9% 
Immunoprecipitation assay and mass spectral analysis
Lysates from P7 mouse brain tissue were extracted by the addition of lysis buffer (20 mM Tris -HCl, 1 mM EDTA, 50 mM NaCl, 1.0% NP-40 and Complete Protease Inhibitor Cocktail) and were cleared by centrifugation at 100 000g for 60 min at 48C. The supernatants were incubated with Nterminal or C-terminal anti-DISC1 antibodies for 1 h at 48C, and the immunocomplexes were precipitated using protein A-Sepharose 4B beads (GE Healthcare). The immunocomplexes were washed three times with lysis buffer and were eluted by boiling in SDS -PAGE sample buffer. The eluate was separated by SDS -PAGE, and the gel was silver-stained using the SilverQuest Silver Staining Kit (Invitrogen). The protein band corresponding to the 100 kDa DISC1 polypeptide was excised from the gel. Gel pieces were destained, reduced, S-carboxymethylated and digested with trypsin. The resulting peptides were subjected to nano-electrospray tandem mass spectroscopic analysis using a Finnigan LTQ Orbitrap XL mass spectrometer (Thermo Fisher, San Jose, CA, USA) combined with a Paradigm MS4 HPLC system (Michrom BioResources Inc., Auburn, CA, USA).
Cresyl violet (Nissl) staining
Paraffin-embedded brain tissue sections were deparaffinized and placed in 0.5% cresyl violet in distilled water at 378C for 10 min. The sections were briefly rinsed twice in 90% ethanol and were dipped in 100% ethanol three times before being dehydrated in xylene three times for 5 min each. The sections were affixed to glass cover slips using Permount solution and were examined under a light microscope.
Immunostaining
Mice were transcardially perfused with 2% paraformaldehyde (PFA) in 100 mM phosphate buffer (PB) (pH 7.4) on day P2. The brains were removed, post-fixed with 2% PFA for 6 h and sectioned sagittally with a cryostat (Leica Microsystems, Wetzlar, Germany) at 10 mm. The sections were blocked using blocking buffer [100 mM PB (pH 7.4), 0.005% saponin, 1% Block Ace (DS Pharma Biomedical, Suita, (23) Pletnikov and Ayhan (25, 85) Li (24) Niwa (48) Clapcote and Lipina (22, 86) Koike and Kvajo (27, 28) Present study Hippocampal neurons were prepared from mouse embryos at embryonic day 16 (E16) using papain (76) . The neurons were seeded on poly-D-lysine-and laminin-coated cover slips and were cultured in Neurobasal medium (Invitrogen) supplemented with the B-27 supplement (Invitrogen) and 1 mM glutamine. The hippocampal neurons at day in vitro (DIV) 3 and DIV8 were fixed with 4% PFA in PB for 10 min and were treated with blocking buffer for 10 min. The neurons were incubated with primary antibodies in the antibody dilution buffer overnight at 48C, washed three times in wash buffer and incubated for 1 h with Alexa Fluor 488 goat anti-rabbit IgG and Alexa Fluor 555 goat anti-mouse IgG in the antibody dilution buffer for 1 h at RT.
Immunofluorescence was performed using a laser scanning confocal microscope (Model LSM 5 Pascal, Zeiss, Oberkochen, Germany and Nikon-A1, Nikon, Tokyo, Japan).
Immunoelectron microscopy
Immunoelectron microscopy using the silver-enhanced immunogold method was performed as previously described (77) . P2 mouse brains and cultured hippocampal neurons at DIV5 were fixed with 2% PFA in 100 mM PB (pH 7.4) and incubated at RT for 5 h with the primary anti-DISC1 Cterminal antibody described above followed by incubation with a secondary anti-rabbit antibody coupled to 1.4 nm gold particles (Nanoprobes Inc., Yaphank, NY, USA). The sample-bound gold particles were silver-enhanced using the HQ-silver kit (Nanoprobes Inc.) at RT for 8 min. The samples were post-fixed with 0.5% osmium oxide in a buffer (pH 7.3) containing 100 mM cacodylate. The samples were dehydrated by passage through a graded series of ethanol (50, 70, 90 and 100%) and propylene oxide and embedded in epoxy resin. From this sample, ultrathin sections were cut, stained with uranyl acetate and lead citrate and observed with an electron microscope (JEM-1011 EX; JEOL, Akishima, Tokyo, Japan).
Hippocampal slice preparation
Electrophysiological analyses were conducted on 3-week-old male mice. The mice were decapitated under deep anesthesia with ethyl ether. The brains were quickly removed, and transverse 400 mm thick slices were cut from the hippocampus using a vibratome in ice-cold artificial cerebrospinal fluid (ACSF) containing 128 mM NaCl, 5 mM KCl, 1.3 mM MgSO 4 , 1.25 mM KH 2 PO 4 , 2.41 mM CaCl 2 , 26 mM NaHCO 3 and 10 mM D-glucose. The ACSF was gassed with 95% O 2 /5% CO 2 , and its pH was adjusted to 7.4. The slices were maintained for at least 1 h at RT (26 -288C) in an incubation chamber containing gassed ACSF.
Electrophysiology
A single hippocampal slice was transferred to the recording chamber and superfused continuously with gassed ACSF at a rate of 2 -2.5 ml/min at RT. A stimulating electrode (monopolar stimulation) was positioned in the molecular layer 30-50 mm from the granule cell layer in the dentate gyrus to activate the medial perforant path. Constant-current pulses (100 ms) were supplied by a stimulator (SEN-3301, Nihon Kohden, Tokyo, Japan) every 30 s. The intensity of the test stimuli was adjusted to evoke 50% of the maximum response. Using the conventional extracellular recording technique, fEPSPs were recorded from the middle molecular layer in the dentate gyrus with a glass pipette filled with 2 M NaCl (2 -3 MV). Baseline recordings were established by delivering test stimuli for more than 60 min before the experimental recordings. LTP was induced by 100 pulses at 50, 100 and 200 Hz. The signals were amplified and filtered at 5 kHz with an amplifier (Axopatch 200B, Axon Instruments, CA, USA). Data acquisition and analysis were performed using pCLAMP 9.0 software (Axon Instruments). The data are expressed as the mean + SD; N indicates the number of slices tested, and one slice was prepared from each mouse. The synaptic transmission in the extracellular recordings was estimated from the rising phase of the fEPSP slope using linear regression during the first 0.6 ms after the PSFV (78) . The magnitude of LTP was expressed as the mean percentage change occurring 55 -60 min after HFS with respect to the final 5 min of the baseline period. Comparisons were made using a two-tailed t-test for paired or independent samples. P-values below 0.05 were considered to be statistically significant.
Behavioral analyses
Information about the open field test (79), the locomotor activity test (79) , the Y-maze test (80) , the PPI test (79) , the fear conditioning test (80) , the elevated plus-maze test (81), the novel object recognition test (82) , the social interaction test (79, 80) , the forced swim test (81) , the latent inhibition test (83) , the cliff-avoidance test (84) and the radial-maze test (85) is provided in the Supplementary Information section. Monoamine metabolism was analyzed as described previously (86) . The data are presented as the mean + SE. Differences between two groups were analyzed using a twotailed Student's t-test. Differences in pre-pulse inhibition, locomotor activity and results of the social interaction test were analyzed by a repeated ANOVA. The time-course data in the cliff-avoidance test were analyzed by the log-rank test. The effect of clozapine treatment was analyzed by a two-way ANOVA followed by Tukey -Kramer post hoc tests.
